Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1286.22x is in line with its 3-year average of -1194.36x, near the high end of its 3-year range (-4395.65x–-445.99x).
8.87% above its 12-month average of -1411.39x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -889.15x.
INTEREST COVERAGE RATIO
-1286.22x
INTEREST COVERAGE RATIO AVG TTM
-1411.39x
INTEREST COVERAGE RATIO AVG 3Y
-1194.36x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+8.87%
CURRENT VS 3Y AVG
-7.69%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
-30524.29%
vs the sector median at left
Anteris Technologies Global Corp.
Market Cap
$734.10M
Interest Coverage Ratio
-1286.22x
TTM Avg
-1411.39x
3Y Avg
-1194.36x
5Y Avg
N/A
Market Cap
$719.64M
Interest Coverage Ratio
-67.01x
TTM Avg
15.61x
3Y Avg
8.76x
5Y Avg
6.40x
Market Cap
$749.55M
Interest Coverage Ratio
-22.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$709.33M
Interest Coverage Ratio
2.27x
TTM Avg
2.29x
3Y Avg
1.77x
5Y Avg
1.65x
Market Cap
$767.46M
Interest Coverage Ratio
N/A
TTM Avg
578.36x
3Y Avg
578.36x
5Y Avg
578.36x
Market Cap
$698.60M
Interest Coverage Ratio
-696.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$774.32M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$775.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anteris Technologies Global Corp. (AVR) | $734.10M | -1286.22x | -1411.39x | -1194.36x | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $719.64M | -67.01x | 15.61x | 8.76x | 6.40x |
| Candel Therapeutics, Inc. (CADL)vs › | $749.55M | -22.78x | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.33M | 2.27x | 2.29x | 1.77x | 1.65x |
| Helus Pharma Inc. (HELP)vs › | $707.86M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $767.46M | N/A | 578.36x | 578.36x | 578.36x |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | -696.50x | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.32M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $776.24M | -1.65x | N/A | N/A | N/A |
Interest Coverage
-1286.2x
Debt/Equity
0.01
Current Ratio
14.20
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -889.15x |
| 2025-12-31 | -2896.50x |
| 2025-09-30 | -1484.33x |
| 2025-06-30 | -949.27x |
| 2025-03-31 | -837.69x |
| 2024-12-31 | -491.58x |
| 2024-09-30 | -1864.28x |
| 2024-06-30 | -1893.09x |
| 2024-03-31 | -1019.49x |
| 2023-12-31 | -1083.82x |
| 2023-09-30 | -445.99x |
| 2023-06-30 | -4395.65x |
| 2023-03-31 | -477.15x |
